(Q35139242)

6 August 2017

1 reference

title

Ezetimibe for management of hypercholesterolemia (English)

1 reference

6 August 2017

0 references

Vincent F Mauro

1

1 reference

6 August 2017

Chad E Tuckerman

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Annals of Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

37

1 reference

6 August 2017

issue

6

1 reference

6 August 2017

page(s)

839-848

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

6 August 2017

cites work

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

New horizons in combination drug therapy for hypercholesterolemia

21 January 2018

1 reference

2-Azetidinones as inhibitors of cholesterol absorption.

21 January 2018

1 reference

Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

21 January 2018

1 reference

Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function

21 January 2018

1 reference

Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)-(4 -hydroxyphenyl)-2-azetidinone (SCH 58235): a designed, potent, orally active inhibitor of cholesterol absorption

21 January 2018

1 reference

Therapeutic potential of ACAT inhibitors as lipid lowering and anti-atherosclerotic agents

21 January 2018

1 reference

2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.

21 January 2018

1 reference

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

21 January 2018

1 reference

The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs

21 January 2018

1 reference

A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe

21 January 2018

1 reference

Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663

21 January 2018

1 reference

Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects

21 January 2018

1 reference

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies

21 January 2018

1 reference

The plasma concentration and LDL-C relationship in patients receiving ezetimibe

21 January 2018

1 reference

The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys

21 January 2018

1 reference

Inhibition of intestinal cholesterol absorption by ezetimibe in humans

21 January 2018

1 reference

Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia

21 January 2018

1 reference

Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia

21 January 2018

1 reference

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

21 January 2018

1 reference

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia

21 January 2018

1 reference

Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia

21 January 2018

1 reference

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C209

1 reference

6 August 2017

1 reference